Jenni Küblbeck

University of Eastern Finland — Finland

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

17h-index972citations42works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacogenetics and Drug Metabolism(19), Estrogen and related hormone effects(11), Effects and risks of endocrine disrupting chemicals(7), Hormonal Regulation and Hypertension(7), Receptor Mechanisms and Signaling(5)

Publications42 total

Functional polymorphisms in pigmentation-related genes MC1R and DCT display population-specific association with wet age-related macular degeneration
Biochemistry and Biophysics Reports·2026Open Access
Unmasking metabolic disruptors: The NEMESIS project's quest for Novel Biomarkers, Evidence on Adverse Effects, and Efficient Methodologies
Open Research Europe·2025Open Access
Drug-Free Approach to Regulate Undruggable Proto-Oncogene MYC Using Biomimetic Porous Nanoparticles for Cancer Immunotherapy
ACS Applied Materials & Interfaces·2025
Nuclear receptors CAR and PXR as cardiometabolic regulators
Pharmacological Research·2025· 5 citedOpen Access
Activation of steroid hormone receptors by metabolism-disrupting chemicals
Toxicology and Applied Pharmacology·2025· 1 citedOpen Access
Look What You Made Me Do: Discerning Feature for Classification of Endocrine-Disrupting Chemical Binding to Steroid Hormone Receptors
Journal of Chemical Information and Modeling·2025· 1 citedOpen Access
Uncovering α-Selectivity for Liver X Receptor Agonists for Lipotoxic Cancer Therapies
Journal of Medicinal Chemistry·2025· 2 citedOpen Access
Association between phthalate exposure and metabolic dysfunction-associated steatotic liver disease (MASLD) – Systematic literature review
Environmental Research·2025· 8 citedOpen Access
Metabolic disruption by mycotoxins: focus on metabolic endpoints steatosis, adipogenesis and glucose metabolism in vivo and in vitro
Archives of Toxicology·2025· 6 citedOpen Access
Cancer Cells Show Higher Sensitivity to Melatonin-Tamoxifen Drug Conjugates than to Combination of Melatonin and Tamoxifen
ACS Omega·2024· 2 citedOpen Access
Unmasking metabolic disruptors: The NEMESIS project's quest for Novel Biomarkers, Evidence on Adverse Effects, and Efficient Methodologies
Open Research Europe·2024· 1 citedOpen Access
P11-03 Exposure to phthalates impair hepatic lipid metabolism and mitochondrial function
Toxicology Letters·2024
The KEAP1-NRF2 pathway: Targets for therapy and role in cancer
Redox Biology·2023· 220 citedOpen Access
Gefitinib-Tamoxifen Hybrid Ligands as Potent Agents against Triple-Negative Breast Cancer
Journal of Medicinal Chemistry·2022· 27 cited
Profiling the regulatory interplay of BET bromodomains and Sirtuins in cancer cell lines
Biomedicine & Pharmacotherapy·2022· 5 citedOpen Access
A toxicogenomic data space for system-level understanding and prediction of EDC-induced toxicity
Environment International·2021· 17 citedOpen Access
Screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cells
Biomedicine & Pharmacotherapy·2021· 17 citedOpen Access
Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR
Cells·2020· 50 citedOpen Access
Effects of galloflavin and ellagic acid on sirtuin 6 and its anti-tumorigenic activities
Biomedicine & Pharmacotherapy·2020· 30 citedOpen Access
The EDCMET Project: Metabolic Effects of Endocrine Disruptors
International Journal of Molecular Sciences·2020· 40 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Paavo Honkakoski(28), Ferdinand Molnár(7), Sini Pitkänen(6), Anna–Liisa Levonen(6), Johanna Jyrkkärinne(6), Antti Poso(6), Jukka Hakkola(5), Viktória Prantner(5), Jaana Rysä(5), Vittorio Fortino(4), Maija Lahtela‐Kakkonen(4), Aleksanteri Petsalo(4), Thales Kronenberger(4), Jonna Niskanen(3), Björn Windshügel(3), Tuomo Laitinen(3), Wolfgang Sippl(3), Minna Rahnasto‐Rilla(3), Marjo Huovinen(3), Juha T. Pulkkinen(3)